Effects of Intermittent Fasting on Experimental Autoimune Encephalomyelitis in C57BL/6 Mice
-
Soodeh Razeghi Jahromi
,
Amir Ghaemi
,
Akram Alizadeh
,
Fatemeh Sabetghadam
,
Hedieh Moradi Tabriz
,
Mansoureh Togha
Abstract
Several religions recommend periods of fasting. One of the most frequently asked questions of MS patients before the holy month of Ramadan is weather fasting might have an unfavorable effect on their disease course. This debate became more challenging after the publication of experimental studies suggesting that calorie restriction prior to disease induction attenuates disease severity. We conducted this study to assess early and late effects of fasting on the animal model of MS, known as autoimmune encephalomyelitis. EAE was induced in the C57BL/6 mice, using Myelin Oligodendrocyte Glycopeptide (MOG) 35-55 and they fasted every other day either after the appearance of the first clinical sign or 30 days after disease induction for ten days. Thereafter, the mice were sacrificed for further histological and immunological evaluations. Intermittent fasting after the establishment of EAE did not have any unfavorable effect on the course of disease. Moreover, fasting at the early phase of disease alleviated EAE severity by ameliorating spinal cord demyelination. Fasting suppressed the secretion of IFN-γ, TNF-α and raised IL-10 production in splenocytes. Fasting was also associated with a lower percent of cytotoxicity. Intermittent fasting not only had no unfavorable effect on EAE but also reduced EAE severity if started at early phase of disease.
1. Jahromi SR, Sahraian MA, Ashtari F, Ayramloo H, Etemadifar M, Ghaffarpour M, et al. Islamic fasting and multiple sclerosis. BMC Neurol 2014;14:56.
2. Schattling B, Eggert B, Friese MA. Acquired channelopathies as contributors to development and progression of multiple sclerosis. Exp Neurol 2014;262:28-36.
3. Wingerchuk DM, Lucchinetti CF, Noseworthy JH.Multiple sclerosis: current pathophysiological concepts. Lab Invest 2001; 81(3):263-81.
4. Piccio L, Stark JL, Cross AH. Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis. J Leukoc Biol 2008; 84(4):940-8.
5. Esquifino A, Cano P, Jimenez V, Cutrera R, Cardinali D.Experimental allergic encephalomyelitis in male Lewis rats subjected to calorie restriction. J Physiol Biochem 2004; 60(4):245-52.
6. Razeghi Jahromi S, Arrefhosseini SR, Ghaemi A, Alizadeh A, Moradi Tabriz H, Togha M. Alleviation of Experimental Allergic Encephalomyelitis in C57BL/6 Mice by Soy Daidzein. Iran J Allergy Asthma Immunol 2014; 13(4):256-264.
7. Esquifino AI, Cano P, Jimenez-Ortega V, Fernández- Mateos MP, Cardinali DP. Immune response after experimental allergic encephalomyelitis in rats subjected to calorie restriction. J Neuroinflammation 2007; 4:6.
8. Renno T, Taupin V, Bourbonnière L, Verge G, Tran E, De Simone R, et al. Interferon-γ in progression to chronic demyelination and neurological deficit following acute EAE. Mol Cell Neurosci 1998; 12(6):376-89.
9. Chitnis T, Khoury SJ. Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis. Immunol Res 2003; 28(3):223-39.
10. Issazadeh S, Mustafa M, Ljungdahl Å, Höjeberg B, Dagerlind Å, Elde R, et al. Interferon γ, interleukin 4 and transforming growth factor β in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J Neurosci Res 1995;40(5):579-90.
11. Issazadeh S, Navikas V, Schaub M, Sayegh M, Khoury S.Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J Immunol 1998;161(3):1104-12.
12. Chitnis T, Najafian N, Benou C, Salama AD, Grusby MJ, Sayegh MH, et al. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J Clin Invest 2001; 108(5):739-47.
13. Panitch HS, Hirsch RL, Schindler J, Johnson KP.Treatment of multiple sclerosis with gamma interferon Exacerbations associated with activation of the immune system. Neurology 1987; 37(7):1097-102.
14. Furlan R, Bergami A, Lang R, Brambilla E, Franciotta D, Martinelli V, et al. Interferon-β treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-γ and interleukin-4. J Neuroimmunol 2000; 111(1-2):86-92.
15. Ugochukwu NH, Figgers CL. Caloric restriction inhibits up-regulation of inflammatory cytokines and TNF-α, and activates IL-10 and haptoglobin in the plasma of streptozotocin-induced diabetic rats. J Nutr Biochem 2007; 18(2):120-6.
16. Jung SH, Park HS, Kim K-S, Choi WH, Ahn CW, Kim BT, et al. Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss. J Nutr Biochem 2008; 19(6):371-5.
17. Samoilova EB, Horton JL, Hilliard B, Liu T-ST, Chen Y.IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J Immunol 1998; 161(12):6480-6.
18. Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA, Kuchroo VK. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10-and IL-4-deficient and transgenic mice. J Immunol 1998; 161(7):3299-306.
19. Rott O, Fleischer B, Cash E. Interleukin‐10 prevents experimental allergic encephalomyelitis in rats. European journal of immunology. 1994;24(6):1434-40.
20. Kuroda Y, Shimamoto Y. Human tumor necrosis factor-α augments experimental allergic encephalomyelitis in rats. J Neuroimmunol 1991; 34(2-3):159-64.
21. Issazadeh S, Lorentzen JC, Mustafa MI, Höjeberg B, Miissener Å, Olsson T. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-β. Journal of neuroimmunology. 1996;69(1):103-15.
22. Stromnes IM, Goverman JM. Passive induction of experimental allergic encephalomyelitis. Nat Protoc 2006; 1(4):1952-60.
23. Adcock IM, Caramori G. Cross-talk between pro- inflammatory transcription factors and glucocorticoids. Immunol Cell Biol 2001; 79(4):376-84.
24. Myhr K, Mellgren S. Corticosteroids in the treatment of multiple sclerosis. Acta Neurol Scand Suppl 2009; (189):73-80.
25. Bolton C, O’Neill J, Allen S, Baker D. Regulation of chronic relapsing experimental allergic encephalomyelitis by endogenous and exogenous glucocorticoids. Int Arch Allergy Immunol 1997; 114(1):74-80.
26. Du C, Liu C, Kang J, Zhao G, Ye Z, Huang S, et al.MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 2009; 10(12):1252-9.
| Files | ||
| Issue | Vol 15, No 3 (2016) | |
| Section | Original Article(s) | |
| Keywords | ||
| Calorie restriction Experimental autoimmune encephalomyelitis Fasting Immunity Inflammation Multiple sclerosis | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
